Literature DB >> 16569743

A mutagenetic tree hidden Markov model for longitudinal clonal HIV sequence data.

Niko Beerenwinkel1, Mathias Drton.   

Abstract

RNA viruses provide prominent examples of measurably evolving populations. In human immunodeficiency virus (HIV) infection, the development of drug resistance is of particular interest because precise predictions of the outcome of this evolutionary process are a prerequisite for the rational design of antiretroviral treatment protocols. We present a mutagenetic tree hidden Markov model for the analysis of longitudinal clonal sequence data. Using HIV mutation data from clinical trials, we estimate the order and rate of occurrence of seven amino acid changes that are associated with resistance to the reverse transcriptase inhibitor efavirenz.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16569743     DOI: 10.1093/biostatistics/kxj033

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  13 in total

1.  A phylogenetic and Markov model approach for the reconstruction of mutational pathways of drug resistance.

Authors:  Patricia Buendia; Brice Cadwallader; Victor DeGruttola
Journal:  Bioinformatics       Date:  2009-08-03       Impact factor: 6.937

2.  Models of RNA virus evolution and their roles in vaccine design.

Authors:  Samuel Ojosnegros; Niko Beerenwinkel
Journal:  Immunome Res       Date:  2010-11-03

3.  HIV-1 diversity after a class switch failure.

Authors:  Michael A Kolber; Patricia Buendia; Victor Degruttola; Richard D Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09-21       Impact factor: 2.205

4.  What do molecules do when we are not looking? State sequence analysis for stochastic chemical systems.

Authors:  Pavel Levin; Jérémie Lefebvre; Theodore J Perkins
Journal:  J R Soc Interface       Date:  2012-09-12       Impact factor: 4.118

5.  HIV-1 mutational pathways under multidrug therapy.

Authors:  Glenn Lawyer; André Altmann; Alexander Thielen; Maurizio Zazzi; Anders Sönnerborg; Thomas Lengauer
Journal:  AIDS Res Ther       Date:  2011-07-27       Impact factor: 2.250

6.  Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-score.

Authors:  Alessandro Cozzi-Lepri; Mattia C F Prosperi; Jesper Kjær; David Dunn; Roger Paredes; Caroline A Sabin; Jens D Lundgren; Andrew N Phillips; Deenan Pillay
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

7.  A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes.

Authors:  Kathleen M Doherty; Priyanka Nakka; Bracken M King; Soo-Yon Rhee; Susan P Holmes; Robert W Shafer; Mala L Radhakrishnan
Journal:  BMC Bioinformatics       Date:  2011-12-15       Impact factor: 3.169

Review 8.  Getting started in probabilistic graphical models.

Authors:  Edoardo M Airoldi
Journal:  PLoS Comput Biol       Date:  2007-12       Impact factor: 4.475

9.  Inferring within-patient HIV-1 evolutionary dynamics under anti-HIV therapy using serial virus samples with vSPA.

Authors:  Naoki Hasegawa; Wataru Sugiura; Junko Shibata; Masakazu Matsuda; Fengrong Ren; Hiroshi Tanaka
Journal:  BMC Bioinformatics       Date:  2009-10-29       Impact factor: 3.169

10.  Quantifying cancer progression with conjunctive Bayesian networks.

Authors:  Moritz Gerstung; Michael Baudis; Holger Moch; Niko Beerenwinkel
Journal:  Bioinformatics       Date:  2009-08-19       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.